Mark is a Consultant Pharmacist in infectious diseases at Imperial College Healthcare NHS Trust. He is also Professor of Practice (infectious diseases) at Imperial College London. Mark is Chair of the Royal Pharmaceutical Society Expert Advisory Group of AMR, and Co-Lead of the UK OPAT Initiative (British Society for Antimicrobial Chemotherapy).